Dr. Peter Samuel Galatin, MD, PhD

Dr. Galatin practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Galatin's NPI, 1942311386, was assigned on August 31, 2006. Dr. Galatin graduated from VCU School of Medicine in 2002. Dr. Galatin's California license number on file is A85095.

Dr. Galatin's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Galatin's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Galatin is also affiliated with El Camino Health - Mountain View Hospital. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Galatin to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Galatin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galatin practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Galatin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Galatin is board certified in hematology by the American Board of Internal Medicine. Dr. Galatin has a license on file in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Galatin treats.

CMS data shows 3,252 Medicare services from Dr. Galatin across 10 procedure codes in 2024, for 572 Medicare patients. Medicare paid $219,056 for them.

CMS counts 572 Medicare patients who saw Dr. Galatin in 2024. The largest group is 75 to 84, with 224 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Galatin's median patient age at 67, with 52% women.

In 2024, Dr. Galatin wrote 921 Medicare Part D claims for 171 patients. 56% of them were for generic drugs. CMS names the drug for 672 of them, across 25 drugs with 11 or more claims each, at $3,324,682 in total drug cost. In 2023, CMS named 568 claims across 21 drugs.

Dr. Galatin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Galatin as offering telehealth.

Dmand AI links 4 papers to Dr. Galatin in 2021. Dr. Galatin's most frequent co-authors are Douglas W. Blayney, MD, Joel William Neal, MD, PhD and Kavitha Jennifer Ramchandran, MD.

CMS Open Payments shows 8 general payments to Dr. Galatin from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. Stryker Corporation paid the most, $492.

Dmand AI lists 1 award for Dr. Galatin, most recently CMS Stage 1 EHR in 2012.

Dr. Galatin graduated from VCU School of Medicine in 2002.

Dr. Galatin is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.